For the quarter ending 2025-09-30, SILO has $6,384,681 in assets. $1,375,841 in debts. $3,917,627 in cash and cash equivalents.
| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 3,917,627 | 4,333,672 | ||
| Short-term investments | 1,948,579 | 1,926,297 | ||
| Crypto assets, at fair value | 72,283 | - | ||
| Prepaid expenses and other current assets | 225,880 | 113,062 | ||
| Total current assets | 6,164,369 | 6,373,031 | ||
| Intangible assets, net | 220,312 | 223,250 | ||
| Prepaid expenses and other assets - non-current | - | 56,226 | ||
| Total long-term assets | 220,312 | 279,476 | ||
| Total assets | 6,384,681 | 6,652,507 | ||
| Accounts payable and accrued expenses | 636,237 | 977,795 | ||
| Deferred revenue - current portion | 72,102 | 72,102 | ||
| Total current liabilities | 708,339 | 1,049,897 | ||
| Deferred revenue - long-term portion | 667,502 | 685,527 | ||
| Total long-term liabilities | 667,502 | 685,527 | ||
| Total liabilities | 1,375,841 | 1,735,424 | ||
| Common stock, 0.0001 par value, 100,000,000 shares authorized 10,461,130 and 4,484,456 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively | 1,046 | 865 | ||
| Additional paid-in capital | 23,607,308 | 22,407,075 | ||
| Accumulated other comprehensive income | 11,345 | 9,564 | ||
| Accumulated deficit | -18,610,859 | -17,500,421 | ||
| Total stockholders equity | 5,008,840 | 4,917,083 | ||
| Total liabilities and stockholders equity | 6,384,681 | 6,652,507 | ||
Silo Pharma, Inc. (SILO)
Silo Pharma, Inc. (SILO)